Paper
1 May 2007 Using delayed chemiluminescence as a photodynamic therapy dose metric in vivo
Author Affiliations +
Proceedings Volume 6534, Fifth International Conference on Photonics and Imaging in Biology and Medicine; 65342H (2007) https://doi.org/10.1117/12.741308
Event: Fifth International Conference on Photonics and Imaging in Biology and Medicine, 2006, Wuhan, China
Abstract
Photodynamic therapy (PDT) is an important method to treat tumor. It is known that singlet oxygen (1O2) is the main factor mediating cytotoxicity in PDT. The effectiveness of a PDT treatment is directly linked to the 1O2 produced in the target. So to control the dose of 1O2 is very important. Although the luminescence from 1O2 can be detected and is suggested as an indicator for evaluating photodynamic therapy, the inherited disadvantages limit its potential for in vivo applications. We have previously reported that chemiluminescence (CL) can be used to detect 1O2 production in PDT and linked the signal to the cytotoxicity, but the irradiation of laser decrease the sensitivity of the detection in vivo. During PDT the high sensitivity probe, Fluoresceinyl Cypridina Luciferin Analog (FCLA), is used to monitor 1O2. In order to avoid the infection of irradiation light, the delayed CL of FCLA is used to indicate 1O2. After recording the delayed CL during PDT and scoring the skin of mice after PDT, the statistic analysis was done. The data shows a remarkable relationship between the score and the CL. the result suggests that the CL can be used as a dose metric in vivo in PDT.
© (2007) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Yanchun Wei, Da Xing, and Qun Chen "Using delayed chemiluminescence as a photodynamic therapy dose metric in vivo", Proc. SPIE 6534, Fifth International Conference on Photonics and Imaging in Biology and Medicine, 65342H (1 May 2007); https://doi.org/10.1117/12.741308
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Photodynamic therapy

In vivo imaging

Chemiluminescence

Oxygen

Luminescence

Skin

Tumors

Back to Top